Aims To investigate the effects of combined therapy with an anticholinergic agent and a β3‐
adrenoceptor agonist on bladder dysfunction and proliferation‐related molecule expression …

Aims To examine vibegron effects on lower urinary tract dysfunction (LUTD) in mice with
spinal cord injury (SCI). Methods Female mice underwent Th8‐9 spinal cord transection and …

Aims To compare the dose effect relationship of a selective β3‐adrenoceptor agonist (CL‐
316,243) on cystometric parameters in anesthetized and conscious rats and to evaluate its …

Aims In order to clarify whether an alpha1A/D‐adrenoceptor (α1A/D‐AR) antagonist,
naftopidil, or a phosphodiesterase type 5 (PDE5) inhibitor, tadalafil, prevents bladder wall …

Purpose The functions of the lower urinary tract (LUT), such as voiding and storing urine, are
dependent on complex central neural networks located in the brain, spinal cord, and …

Objectives To investigate the effect of vibegron, a new clinically approved β3‐adrenoceptor
agonist in lower urinary tract dysfunction in mice with spinal cord injury. Methods …

Objective To investigate the effects of early tamsulosin treatment on changes in bladder
characteristics after a spinal cord injury. Methods We divided 45 rats into three groups: the …

Purpose: We investigated the effects of intrathecal application of γ-aminobutyric acid A and
B receptor agonists on detrusor overactivity in spinal cord injured rats. Materials and …

Spinal cord injury (SCI) rostral to the lumbosacral level causes bladder hyperreflexia and
detrusor-sphincter dyssynergia (DSD), which are accompanied by bladder hypertrophy. We …

Objectives. To determine the feasibility of urodynamic monitoring of voiding function in
conscious, female spinal cord-injured (SCI) rats and to compare the voiding function in SCI …